Evidence map›Paper›PMID 34709182›Full record

ArticleJMIR formative research2021

Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study.

Nayra A Martin-Key, Dan-Mircea Mirea, Tony Olmert, Jason Cooper, Sung Yeon Sarah Han, Giles Barton-Owen, Lynn Farrag, Emily Bell, Pawel Eljasz, Daniel Cowell and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nayra A Martin-KeyCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-9731-3809
Dan-Mircea MireaCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-4349-7059
Tony OlmertCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-4641-6442
Jason CooperCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-2459-5286
Sung Yeon Sarah HanCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-1459-2516
Giles Barton-OwenPsyomics Ltd, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-7552-1295
Lynn FarragPsyomics Ltd, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-5045-5308
Emily BellPsyomics Ltd, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-2037-3093
Pawel EljaszCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-0592-3934
Daniel CowellPsyomics Ltd, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-6061-3544
Jakub TomasikCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-2127-4487
Sabine BahnCambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-4690-6302
University of Cambridge · GBPrinceton University · USSentinel Oncology (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosing major depressive disorder (MDD) is challenging, with diagnostic manuals failing to capture the wide range of clinical symptoms that are endorsed by individuals with this condition.

objectiveThis study aims to provide evidence for an extended definition of MDD symptomatology.

methodsSymptom data were collected via a digital assessment developed for a delta study. Random forest classification with nested cross-validation was used to distinguish between individuals with MDD and those with subthreshold symptomatology of the disorder using disorder-specific symptoms and transdiagnostic symptoms. The diagnostic performance of the Patient Health Questionnaire-9 was also examined.

resultsA depression-specific model demonstrated good predictive performance when distinguishing between individuals with MDD (n=64) and those with subthreshold depression (n=140) (area under the receiver operating characteristic curve=0.89; sensitivity=82.4%; specificity=81.3%; accuracy=81.6%). The inclusion of transdiagnostic symptoms of psychopathology, including symptoms of depression, generalized anxiety disorder, insomnia, emotional instability, and panic disorder, significantly improved the model performance (area under the receiver operating characteristic curve=0.95; sensitivity=86.5%; specificity=90.8%; accuracy=89.5%). The Patient Health Questionnaire-9 was excellent at identifying MDD but overdiagnosed the condition (sensitivity=92.2%; specificity=54.3%; accuracy=66.2%).

conclusionsOur findings are in line with the notion that current diagnostic practices may present an overly narrow conception of mental health. Furthermore, our study provides proof-of-concept support for the clinical utility of a digital assessment to inform clinical decision-making in the evaluation of MDD.

Indexed as

digital assessmentdigital mental healthmajor depressive disordermobile phonesubthreshold depression, transdiagnostic symptoms

Identifiers

PMID34709182
PMCPMC8587324
OpenAlexW3189663195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.